Saving changes...

Done

Error

Clinical Implications of Microbiome in Chronic Respiratory Disease

Go Back

Clinical Implications of Microbiome in Chronic Respiratory Disease

Clinical Implications of Microbiome in Chronic Respiratory Disease

Dr. David B. Corry (MD), Dr. Yvonne Huang (MD), and Gary Huffnagle (PhD)
Dr. David B. Corry (MD), Dr. Yvonne Huang (MD), and Gary Huffnagle (PhD)
on behalf of American Academy of Allergy Asthma & Immunology

 $15.00 $ 15.00 $ 15.00

$ 15.00 15.00 15.00
$ 15.00 15.00 15.00
Normal Price: $15.00 $15.00

Review:

Launch date: 04 Jul 2018
Expiry Date:

Last updated: 22 Aug 2018

Reference: 190579

TIming: null

Maximum Attendees:

Places Left: 0

Take CourseTake ExamSelf Verify

This course is no longer available

Exam is embedded in the course
No preview available
No Exam Available

Latest User Comments

See all 0 comments (newest first)

I would like to...

Course Availability

This course is only available to trainees days after purchase. It would need to be repurchased by the trainee if not completed in the allotted time period. This course is no longer available. You will need to repurchase if you wish to take the course again.

You have null days left.

Description

This session will discuss some of the limitations and caveats of the microbiome data, the relationship of the upper and lower respiratory tract between the host and microorganism on the microbiome and clinical implications.

Objectives

Discuss the deep sequencing technology, its limitations and consequences on the understanding of the microbiome, especially the limited understanding of the fungal microbiome
Upon completion of this activity, participants will be able to discuss the deep sequencing technology, its limitations and consequences on the understanding of the microbiome, especially the limited understanding of the fungal microbiome.
Identify current knowledge of airway microbiota and outline how host-microorganism interactions influence health and disease
Upon completion of this activity, participants will be able to identify current knowledge of airway microbiota and outline how host-microorganism interactions influence health and disease.
Discuss how the microbiota in the mouth and nose influences the microorganism communities in the lungs and implications on disease
Upon completion of this activity, participants will be able to discuss how the microbiota in the mouth and nose influences the microorganism communities in the lungs and implications on disease.
Dr. David B. Corry (MD), Dr. Yvonne Huang (MD), and Gary Huffnagle (PhD)

Author Information Play Video Bio

Dr. David B. Corry (MD), Dr. Yvonne Huang (MD), and Gary Huffnagle (PhD)
on behalf of American Academy of Allergy Asthma & Immunology

Dr. David B. Corry, MD, Baylor College of Medicine, Houston, TX

Dr. Yvonne Huang, MD, University of Michigan, Ann Arbor, MI

Prof. Gary Huffnagle, PhD, University of Michigan Medical School, Ann Arbor, MI

Current Accreditations

This course has been certified by or provided by the following Certified Organization/s:

  • Accreditation Council for Continuing Medical Education (ACCME)
  • 1.25 Credits
  • California Board of Registered Nursing (CBRN)
  • 1.25 Hours

Faculty and Disclosures

Dr. David B. Corry, MD

Dr. David B. Corry, MD

No Conflict
Dr. Yvonne Huang, MD

Dr. Yvonne Huang, MD

No Conflict
Gary B. Huffnagle, PhD

Gary B. Huffnagle, PhD

No Conflict

Additional Contributors

Conflicts Declared

Conflicts of Interest declaration by Author:

null

User Reviews (0)

Go Back

Loading...


Saving changes...

Done

Error